folder

Brentuximab vedotin-containing escalated BEACOPP variants for newly diagnosed advanced-stage classical Hodgkin lymphoma: follow-up analysis of a randomized phase II study from the German Hodgkin Study Group

Authors

  • C. Damaschin
  • H. Goergen
  • S. Kreissl
  • A. Plütschow
  • F. Breywisch
  • S. Mathas
  • J. Meissner
  • M. Sökler
  • M.S. Topp
  • V. Vucinic
  • A. Zimmermann
  • B. von Tresckow
  • M. Fuchs
  • A. Engert
  • P. Borchmann
  • D.A. Eichenauer

Journal

  • Leukemia

Citation

  • Leukemia

DOI

doi:10.1038/s41375-021-01386-z